Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
2
Neutral
6
Bullish
6
Bearish
12
Neutral
6
Bullish
28
Bearish
10
Neutral
0
Bullish
22
Pharmaceuticals & Biotechnology
Pharmaceuticals
120 Cr
Low Risk
235.6
37.7
0.1
1.8
126.10
60.00
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
64.04 | 130 Cr | 29.79 | 0.70 | 0.00 | 8.06 | 8.98 | 1.68 | ||
100.50 | 127 Cr | 18.28 | 1.96 | 0.00 | 9.36 | 10.75 | 3.79 | ||
108.20 | 120 Cr | 235.59 | 1.80 | 0.00 | 9.95 | 11.89 | 0.99 | ||
60.00 | 120 Cr | -8.52 | 0.00 | 0.00 | 10.40 | -9.06 | -8.63 | ||
120.53 | 119 Cr | 28.60 | 1.53 | 0.00 | 5.39 | 5.94 | 2.08 | ||
110.00 | 115 Cr | 25.78 | 0.82 | 3.13 | 4.94 | 6.74 | 3.01 | ||
8.14 | 109 Cr | 25.66 | 1.57 | 0.00 | 6.03 | 8.35 | 3.45 | ||
| Median: 7 Co. | — | 100.50 | 120 Cr | 25.78 | 1.53 | 0.00 | 8.06 | 8.35 | 2.08 |
Asston Pharmaceuticals Ltd (APL) is currently trading at 108.20 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Asston Pharmaceuticals Ltd operates in the its sector sector. Review the About Company section on this page to understand its business model, revenue streams, and key products or services.
Over the past 52 weeks, Asston Pharmaceuticals Ltd has traded between a low of ₹60.00 and a high of ₹126.10. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Asston Pharmaceuticals Ltd has a market capitalization of approximately 120.15. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Asston Pharmaceuticals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 235.59 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 120.15 Cr, Asston Pharmaceuticals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Asston Pharmaceuticals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Asston Pharmaceuticals Ltd is 235.59. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
AGM/EGM Notice
Asston Pharmaceuticals Ltd: Notice of 7th AGM on 2026-09-29 at 12:30 P.M. via VC/OAVM. Agenda includes adoption of audited FY2025-26 financials, director/ auditor appointments and increases in MD and CEO remuneration.
Preferential Allotment/QIP
Asston Pharmaceuticals approved allotment of 24,10,431 equity shares at Rs.115 each via preferential allotment; paid-up capital rises to Rs.10,92,27,910 (1,09,22,791 shares). Board meeting held on 2026-09-05.
Board Meeting
Asston Pharmaceuticals: Board on 2026-09-04 approved appointment of internal and statutory auditors, recommended MD re-appointment, approved proposed increases in directors' remuneration (subject to shareholders), approved Board Report, set AGM on 2026-09-29 (12:30 PM, VC) with cut-off 2026-09-22.
Shareholding Pattern
Asston Pharmaceuticals Ltd disclosure: Prakruti R Pali acquired 151,000 shares via open market on 2026-09-01, raising holding from 618,000 (7.26%) to 769,000 shares (9.03%). Disclosure dated 2026-09-03.
